{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:48:26Z","timestamp":1777398506197,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Necroptosis is a novel form of programmed necrotic cell death involved in various autoimmune diseases. The potential role of necroptosis in primary immune thrombocytopenia (ITP) and the possible interlink with autophagy have not been fully investigated. The gene expression of mixed lineage kinase-like domain (MLKL), receptor-interacting protein kinase 3 (RIPK3) and Beclin-1 were quantified in peripheral blood of 45 ITP patients and 20 healthy controls. Their associations with clinical, laboratory parameters and response to steroid therapy in ITP patients were evaluated. RIPK3, MLKL, and Beclin-1 were significantly upregulated in ITP patients than in healthy controls (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Beclin-1 mRNA levels were positively correlated with both RIPK3 and MLKL mRNA levels in ITP patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). In addition, MLKL, RIPK3, and Beclin-1 mRNA levels were inversely correlated with platelet count (<jats:italic>r<\/jats:italic>\u2009=\u2009\u22120.330, \u22120.527 and \u22120.608, respectively). On the hand, positive correlations between MLKL (<jats:italic>P<\/jats:italic>\u2009=\u20090.01), RIPK3 (<jats:italic>P<\/jats:italic>\u2009=\u20090.005), Beclin-1 (<jats:italic>P<\/jats:italic>\u2009=\u20090.002) mRNA levels and severity of bleeding in ITP patients were reported. Steroid responders (<jats:italic>n<\/jats:italic>\u2009=\u200918, 40%) had significantly lower MLKL, RIPK3, Beclin-1 mRNA expression levels than their levels in the non-responders (<jats:italic>n<\/jats:italic>\u2009=\u200927, 60%). Necroptosis may play a critical role in the pathogenesis of ITP and provide both novel therapeutic targets and promising biomarkers for the prediction of bleeding severity and treatment response in ITP patients. Additionally, this study highlighted the crosstalk between autophagy and necroptosis in ITP patients.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s10238-022-00839-8","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T12:04:48Z","timestamp":1655208288000},"page":"447-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Upregulation of necroptosis markers RIPK3\/MLKL and their crosstalk with autophagy-related protein Beclin-1 in primary immune thrombocytopenia"],"prefix":"10.1007","volume":"23","author":[{"given":"Amany M.","family":"Kamal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nermeen A.","family":"Nabih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahed M.","family":"Rakha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5406-2029","authenticated-orcid":false,"given":"Eman F.","family":"Sanad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"839_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495\u2013516.","journal-title":"Toxicol Pathol"},{"key":"839_CR2","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1056\/NEJMra0901217","volume":"361","author":"RS Hotchkiss","year":"2009","unstructured":"Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med. 2009;361:1570\u201383.","journal-title":"N Engl J Med"},{"key":"839_CR3","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1016\/j.bbamcr.2013.06.001","volume":"1833","author":"V Nikoletopoulou","year":"2013","unstructured":"Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N. Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta. 2013;1833:3448\u201359.","journal-title":"Biochim Biophys Acta"},{"key":"839_CR4","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature17649","volume":"534","author":"L Vande Walle","year":"2016","unstructured":"Vande Walle L, Jim\u00e9nez Fern\u00e1ndez D, Demon D, Van Laethem N, Van Hauwermeiren F, Van Gorp H, et al. Does caspase-12 suppress inflammasome activation? Nature. 2016;534:E1-4.","journal-title":"Nature"},{"key":"839_CR5","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.immuni.2019.05.020","volume":"50","author":"N Van Opdenbosch","year":"2019","unstructured":"Van Opdenbosch N, Lamkanfi M. Caspases in cell death, inflammation, and disease. Immunity. 2019;50:1352\u201364.","journal-title":"Immunity"},{"key":"839_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41418-018-0212-6","volume":"26","author":"D Frank","year":"2019","unstructured":"Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26:99\u2013114.","journal-title":"Cell Death Differ"},{"key":"839_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","volume":"3","author":"BT Cookson","year":"2001","unstructured":"Cookson BT, Brennan MA. Pro-inflammatory programmed cell death. Trends Microbiol. 2001;3:113\u20134.","journal-title":"Trends Microbiol"},{"key":"839_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms14128","volume":"8","author":"C Rogers","year":"2017","unstructured":"Rogers C, Fernandes-Alnemri T, Mayes L, Alnemri D, Cingolani G, Alnemri ES. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death. Nat Commun. 2017;8:1\u201314.","journal-title":"Nat Commun"},{"key":"839_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrm2970","volume":"11","author":"P Vandenabeele","year":"2010","unstructured":"Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol cell Biol. 2010;11:700\u201314.","journal-title":"Nat Rev Mol cell Biol"},{"key":"839_CR10","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/cdd.2017.65","volume":"24","author":"S Grootjans","year":"2017","unstructured":"Grootjans S, Vanden Berghe T, Vandenabeele P. Initiation and execution mechanisms of necroptosis: an overview. Cell Death Differ. 2017;24:1184\u201395.","journal-title":"Cell Death Differ"},{"key":"839_CR11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/15384047.2016.1210732","volume":"17","author":"B Hanson","year":"2016","unstructured":"Hanson B. Necroptosis: A new way of dying? Cancer Biol Ther. 2016;17:899\u2013910.","journal-title":"Cancer Biol Ther"},{"key":"839_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1235-0","volume":"15","author":"YK Dhuriya","year":"2018","unstructured":"Dhuriya YK, Sharma D. Necroptosis: a regulated inflammatory mode of cell death. J Neuroinflammation. 2018;15:1\u20139.","journal-title":"J Neuroinflammation"},{"key":"839_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1101\/gad.312561.118","volume":"32","author":"B Shan","year":"2018","unstructured":"Shan B, Pan H, Najafov A, Yuan J. Necroptosis in development and diseases. Genes Dev. 2018;32:327\u201340.","journal-title":"Genes Dev"},{"key":"839_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.52547\/ibj.25.4.265","volume":"25","author":"AM Kamal","year":"2021","unstructured":"Kamal AM, Sebak SA, Sanad EF. Mixed Lineage Kinase Domain-Like Pseudokinase (MLKL) Gene Expression in Human Atherosclerosis with and without Type 2 Diabetes Mellitus. Iran Biomed J. 2021;25:265\u201374.","journal-title":"Iran Biomed J"},{"key":"839_CR15","first-page":"495","volume":"27","author":"G Kistangari","year":"2013","unstructured":"Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Clin. 2013;27:495\u2013520.","journal-title":"Hematol Clin"},{"key":"839_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-981-10-4142-6_4","volume-title":"Ishida Y","author":"T Hato","year":"2017","unstructured":"Hato T, Kurata Y. Epidemiology BT - Autoimmune Thrombocytopenia. In: Tomiyama Y, editor. Ishida Y. Singapore: Springer Singapore; 2017. p. 41\u20139. https:\/\/doi.org\/10.1007\/978-981-10-4142-6_4."},{"key":"839_CR17","first-page":"e5849","volume":"11","author":"M Samson","year":"2019","unstructured":"Samson M, Fraser W, Lebowitz D. Treatments for primary immune thrombocytopenia: a review. Cureus. 2019;11:e5849.","journal-title":"Cureus."},{"key":"839_CR18","first-page":"2829","volume":"129","author":"MP Lambert","year":"2017","unstructured":"Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood J Am Soc Hematol. 2017;129:2829\u201335.","journal-title":"Blood J Am Soc Hematol."},{"key":"839_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/jcm6020016","volume":"6","author":"A Zufferey","year":"2017","unstructured":"Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6:16.","journal-title":"J Clin Med"},{"key":"839_CR20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","volume":"16","author":"S Audia","year":"2017","unstructured":"Audia S, Mah\u00e9vas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017;16:620\u201332.","journal-title":"Autoimmun Rev"},{"key":"839_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-014-0072-6","volume":"7","author":"X Ji","year":"2014","unstructured":"Ji X, Zhang L, Peng J, Hou M. T cell immune abnormalities in immune thrombocytopenia. J Hematol Oncol. 2014;7:1\u20136.","journal-title":"J Hematol Oncol"},{"key":"839_CR22","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fimmu.2018.00880","volume":"9","author":"M Swinkels","year":"2018","unstructured":"Swinkels M, Rijkers M, Voorberg J, Vidarsson G, Leebeek FWG, Jansen AJ. Emerging concepts in immune thrombocytopenia. Front Immunol. 2018;9:880.","journal-title":"Front Immunol"},{"key":"839_CR23","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","volume":"87","author":"JW Semple","year":"1996","unstructured":"Semple JW, Milev Y, Cosgrave D, Mody M, Hornstein A, Blanchette V, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood. 1996;87:4245\u201354.","journal-title":"Blood"},{"key":"839_CR24","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3324\/haematol.2011.046417","volume":"96","author":"AMC Rocha","year":"2011","unstructured":"Rocha AMC, Souza C, Rocha GA, de Melo FF, Clementino NCD, Marino MCA, et al. The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia. Haematologica. 2011;96:1560.","journal-title":"Haematologica"},{"key":"839_CR25","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1053\/j.seminhematol.2013.03.016","volume":"50","author":"S von Gunten","year":"2013","unstructured":"von Gunten S, Wehrli M, Simon H-U. Cell death in immune thrombocytopenia: novel insights and perspectives. Semin Hematol. 2013;50:S109\u201315.","journal-title":"Semin Hematol"},{"key":"839_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/10245332.2016.1237004","volume":"22","author":"G Deng","year":"2017","unstructured":"Deng G, Yu S, Li Q, He Y, Liang W, Yu L, et al. Investigation of platelet apoptosis in adult patients with chronic immune thrombocytopenia. Hematology. 2017;22:155\u201361.","journal-title":"Hematology"},{"key":"839_CR27","first-page":"4016","volume":"18","author":"Z Liu","year":"2018","unstructured":"Liu Z, Mei T. Immune thrombocytopenia induces autophagy and suppresses apoptosis in megakaryocytes. Mol Med Rep. 2018;18:4016\u201322.","journal-title":"Mol Med Rep"},{"key":"839_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-019-0779-0","volume":"19","author":"R Sun","year":"2019","unstructured":"Sun R, Shan N. Megakaryocytic dysfunction in immune thrombocytopenia is linked to autophagy. Cancer Cell Int. 2019;19:1\u201310.","journal-title":"Cancer Cell Int"},{"key":"839_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1160\/TH04-06-0385","volume":"93","author":"B Olsson","year":"2005","unstructured":"Olsson B, Andersson P-O, Jacobsson S, Carlsson L, Wadenvik H. Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura. Thromb Haemost. 2005;93:139\u201344.","journal-title":"Thromb Haemost"},{"key":"839_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-017-0001-6","volume":"3","author":"Q Chen","year":"2018","unstructured":"Chen Q, Kang J, Fu C. The independence of and associations among apoptosis, autophagy, and necrosis. Signal Transduct Target Ther. 2018;3:1\u201311.","journal-title":"Signal Transduct Target Ther"},{"key":"839_CR31","doi-asserted-by":"publisher","first-page":"38904","DOI":"10.1074\/jbc.M111.269134","volume":"286","author":"T Farkas","year":"2011","unstructured":"Farkas T, Daugaard M, J\u00e4\u00e4ttel\u00e4 M. Identification of small molecule inhibitors of phosphatidylinositol 3-kinase and autophagy. J Biol Chem. 2011;286:38904\u201312.","journal-title":"J Biol Chem"},{"key":"839_CR32","doi-asserted-by":"publisher","first-page":"13034","DOI":"10.1073\/pnas.1005997107","volume":"107","author":"SL Osborn","year":"2010","unstructured":"Osborn SL, Diehl G, Han S-J, Xue L, Kurd N, Hsieh K, et al. Fas-associated death domain (FADD) is a negative regulator of T-cell receptor\u2013mediated necroptosis. Proc Natl Acad Sci. 2010;107:13034\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"839_CR33","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3:3780\u2013817.","journal-title":"Blood Adv"},{"key":"839_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2141.2007.06635.x","volume":"138","author":"LK Page","year":"2007","unstructured":"Page LK, Psaila B, Provan D, Michael Hamilton J, Jenkins JM, Elish AS, et al. The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. Br J Haematol. 2007;138:245\u20138.","journal-title":"Br J Haematol"},{"key":"839_CR35","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3:3829\u201366.","journal-title":"Blood Adv"},{"key":"839_CR36","first-page":"756","volume":"42","author":"AM Khan","year":"2017","unstructured":"Khan AM, Mydra H, Nevarez A. Clinical practice updates in the management of immune thrombocytopenia. Pharm Ther. 2017;42:756\u201363.","journal-title":"Pharm Ther"},{"key":"839_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"839_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-020-02332-7","volume":"22","author":"M Zhang","year":"2020","unstructured":"Zhang M, Jie H, Wu Y, Han X, Li X, He Y, et al. Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity. Arthritis Res Ther. 2020;22:1\u20138.","journal-title":"Arthritis Res Ther"},{"key":"839_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2328-0","volume":"11","author":"X Duan","year":"2020","unstructured":"Duan X, Liu X, Liu N, Huang Y, Jin Z, Zhang S, et al. Inhibition of keratinocyte necroptosis mediated by RIPK1\/RIPK3\/MLKL provides a protective effect against psoriatic inflammation. Cell Death Dis. 2020;11:1\u201314.","journal-title":"Cell Death Dis"},{"key":"839_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41577-018-0117-0","volume":"19","author":"SR Paludan","year":"2019","unstructured":"Paludan SR, Reinert LS, Hornung V. DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer. Nat Rev Immunol. 2019;19:141\u201353.","journal-title":"Nat Rev Immunol"},{"key":"839_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.critrevonc.2004.12.004","volume":"54","author":"B Zhou","year":"2005","unstructured":"Zhou B, Zhao H, Yang RC, Han ZC. Multi-dysfunctional pathophysiology in ITP. Crit Rev Oncol Hematol. 2005;54:107\u201316.","journal-title":"Crit Rev Oncol Hematol"},{"key":"839_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21608\/ejhm.2021.138115","volume":"82","author":"MA Hesham","year":"2021","unstructured":"Hesham MA, Esh AMH, Beshik AM. The Contribution of Tumor Necrosis Factor-\u03b1 (TNF-\u03b1) to Pathogenesis of Childhood Primary Immune Thrombocytopenia: Single Center Study. Egypt J Hosp Med. 2021;82:101\u20135.","journal-title":"Egypt J Hosp Med."},{"key":"839_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43042-020-00129-6","volume":"22","author":"MA El-hady","year":"2021","unstructured":"El-hady MA, Mosallam DS, Anis SK, Mansour BS, Yassa ME. Tumor necrosis factor induced protein 3 gene polymorphism and the susceptibility to chronic primary immune thrombocytopenia in Egyptian children: a case-control study. Egypt J Med Hum Genet. 2021;22:1\u20139.","journal-title":"Egypt J Med Hum Genet"},{"key":"839_CR44","doi-asserted-by":"publisher","first-page":"e12992","DOI":"10.1111\/sji.12992","volume":"93","author":"S Liu","year":"2021","unstructured":"Liu S, Zhang X, Sun R, Zhu J, Yuan D, Shan N. Abnormal expression of autophagy-related proteins in immune thrombocytopenia. Scand J Immunol. 2021;93:e12992.","journal-title":"Scand J Immunol"},{"key":"839_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.critrevonc.2016.01.011","volume":"100","author":"N Shan","year":"2016","unstructured":"Shan N, Dong L, Zhang X, Liu X, Li Y. Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy. Crit Rev Oncol Hematol. 2016;100:11\u20135.","journal-title":"Crit Rev Oncol Hematol"},{"key":"839_CR46","doi-asserted-by":"publisher","first-page":"21110","DOI":"10.1074\/jbc.M111.319129","volume":"287","author":"MJ Khan","year":"2012","unstructured":"Khan MJ, Alam MR, Waldeck-Weiermair M, Karsten F, Groschner L, Riederer M, et al. Inhibition of autophagy rescues palmitic acid-induced necroptosis of endothelial cells. J Biol Chem. 2012;287:21110\u201320.","journal-title":"J Biol Chem"},{"key":"839_CR47","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/NEN.0b013e31821352bd","volume":"70","author":"J-Y Wang","year":"2011","unstructured":"Wang J-Y, Xia Q, Chu K-T, Pan J, Sun L-N, Zeng B, et al. Severe global cerebral ischemia-induced programmed necrosis of hippocampal CA1 neurons in rat is prevented by 3-methyladenine: a widely used inhibitor of autophagy. J Neuropathol Exp Neurol. 2011;70:314\u201322.","journal-title":"J Neuropathol Exp Neurol"},{"key":"839_CR48","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1038\/onc.2015.35","volume":"34","author":"B Schenk","year":"2015","unstructured":"Schenk B, Fulda S. Reactive oxygen species regulate Smac mimetic\/TNF\u03b1-induced necroptotic signaling and cell death. Oncogene. 2015;34:5796\u2013806.","journal-title":"Oncogene"},{"key":"839_CR49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1:112\u20139.","journal-title":"Nat Chem Biol"},{"key":"839_CR50","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4161\/auto.9099","volume":"5","author":"Y-T Wu","year":"2009","unstructured":"Wu Y-T, Tan H-L, Huang Q, Ong C-N, Shen H-M. Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy. Autophagy. 2009;5:824\u201334.","journal-title":"Autophagy"},{"key":"839_CR51","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/MOH.0b013e328357010e","volume":"19","author":"JW Rowley","year":"2012","unstructured":"Rowley JW, Schwertz H, Weyrich AS. Platelet mRNA: the meaning behind the message. Curr Opin Hematol. 2012;19:385.","journal-title":"Curr Opin Hematol"},{"key":"839_CR52","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/s41596-019-0139-5","volume":"14","author":"MG Best","year":"2019","unstructured":"Best MG, In\u2019t Veld SGJG, Sol N, Wurdinger T. RNA sequencing and swarm intelligence\u2013enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA. Nat Protoc. 2019;14:1206\u201334.","journal-title":"Nat Protoc"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00839-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00839-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00839-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T16:09:15Z","timestamp":1685203755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00839-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00839-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"4 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethical Committee of Research, Faculty of Medicine, Ain Shams University (Cairo, Egypt), authorized the study, which was carried out in compliance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Each enrolled participant signed an informed consent before study entry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}